[Effects of adrenomedullin on NO release].
Hirata
Yasunobu
Y
Department of Cardiovascular Medicine, University of Tokyo.
D053607:Adrenomedullin; D000818:Animals; D017209:Apoptosis; D006152:Cyclic GMP / Q000502:physiology; D004268:DNA-Binding Proteins / Q000502:physiology; D042783:Endothelial Cells / Q000166:cytology; D005786:Gene Expression Regulation; D006801:Humans; D051793:Hypoxia-Inducible Factor 1; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D018919:Neovascularization, Physiologic; D009569:Nitric Oxide / Q000378:metabolism / Q000502:physiology*; D009687:Nuclear Proteins / Q000502:physiology; D010455:Peptides / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D019869:Phosphatidylinositol 3-Kinases / Q000502:physiology; D017346:Protein Serine-Threonine Kinases / Q000502:physiology; D011518:Proto-Oncogene Proteins / Q000502:physiology; D051057:Proto-Oncogene Proteins c-akt; D012333:RNA, Messenger / Q000378:metabolism; D015427:Reperfusion Injury / Q000517:prevention & control; D014157:Transcription Factors / Q000502:physiology; D014664:Vasodilation
D053607:Adrenomedullin; D006152:Cyclic GMP; D004268:DNA-Binding Proteins; D051793:Hypoxia-Inducible Factor 1; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D009569:Nitric Oxide; D009687:Nuclear Proteins; D010455:Peptides; D019869:Phosphatidylinositol 3-Kinases; D017346:Protein Serine-Threonine Kinases; D011518:Proto-Oncogene Proteins; D051057:Proto-Oncogene Proteins c-akt; D012333:RNA, Messenger; D014157:Transcription Factors; C497442:HIF1A protein, human